Your search returned 76 studies. (Get alerts for new studies):
- N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
Conditions: Neuroblastoma
13 Locations available
- Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neurob
Conditions: Neuroblastoma
163 Locations available
- Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Conditions: Neuroblastoma
15 Locations available
- Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
69 Locations available
- Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
Conditions: Neuroblastoma - Bone Marrow, Sympathetic Nervous System
1 Location available
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Neuroblastoma
206 Locations available
- Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Neuroblastoma - Unspecified Childhood Solid Tumor, Protocol Specific
25 Locations available
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Ovarian Cancer - Testicular Germ Cell Tumor
1 Location available
- Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
Conditions: Neuroblastoma
5 Locations available
- Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transpl
Conditions: Neuroblastoma
8 Locations available
- High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Conditions: Neuroblastoma
85 Locations available
- Natural History Study of Patients With Central Nervous System Tumors Being Evaluated at the National Institutes of Health
Conditions: Brain and Central Nervous System Tumors - Chordoma - Neuroblastoma
2 Locations available
- Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Children With Relapsed or Refractory High-Risk NBL.
Conditions: Neuroblastoma
4 Locations available
- Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell
Conditions: Neuroblastoma
1 Location available
- High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With Hig
Conditions: Neuroblastoma
1 Location available
- High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
Conditions: Neuroblastoma
56 Locations available
- Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
Conditions: Neuroblastoma
6 Locations available
- Molecular-Guided Therapy for Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
Conditions: Breast Cancer - Colon Cancer - Lung Cancer - Neuroblastoma - Testicular Cancer
1 Location available
- Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
Conditions: Neuroblastoma - Medulloblastoma
5 Locations available
- High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Conditions: Childhood Langerhans Cell Histiocytosis - Fanconi Anemia - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Sarcoma - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Intraocular Melanoma - Lung Cancer - Melanoma (Skin) - Metastatic Cancer - Neuroblastoma - Ovarian Cancer - Retinoblastoma - Sarcoma - Small Intestine Cancer
1 Location available
- A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
Conditions: Brain Tumors - Leukemia - Sarcomas - Neuroblastoma - Lymphoma - Hodgkins Disease
1 Location available
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Conditions: Cancer Survivor - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Testicular Germ Cell Tumor
1 Location available
- Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Conditions: Sarcoma - Endocrine Tumors - Neuroblastoma - Retinoblastoma - Renal Cancer
2 Locations available
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
Conditions: Neuroblastoma - Rhabdomyosarcoma - Lymphoma - Wilm's Tumor - Ewing's Sarcoma
2 Locations available
- Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma
Conditions: Neuroblastoma
14 Locations available
- Aflac ST1001 Prolonged Isotretinoin
Conditions: Neuroblastoma
1 Location available
- Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Conditions: Neuroblastoma - Medulloblastoma
7 Locations available
- The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia - Non-Hodgkins Lymphoma - Sarcoma - Neuroblastoma
5 Locations available
- Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
Conditions: Neuroblastoma
30 Locations available
- A Phase 1/2 Study of PF-02341066, An Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children With Relapsed/Refractory
Conditions: Wilms Tumor - Sarcoma - Neuroblastoma - Osteosarcoma - Lymphoma, Large Cell, Anaplastic
2 Locations available
- Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
Conditions: Neuroblastoma - Ewings Sarcoma - Osteogenic Sarcoma - Rhabdomyosarcoma - Synovial Sarcoma
1 Location available
- Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
Conditions: Sarcoma - Wilm's Tumor - Lymphoma - Neuroblastoma
3 Locations available
- Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors
Conditions: Neuroblastoma
1 Location available
- A Safety/Feasibility Trial of the Addition of the Humanized Anti-GD2 Antibody (hu14.18K322A) With and Without Natural Killer Cells to Chemotherapy in
Conditions: Neuroblastoma
1 Location available
- N99-02: Melphalan and Buthionine Sulfoximine Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Children With Resistant or Re
Conditions: Neuroblastoma
8 Locations available
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplan
Conditions: Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Oral Complications - Ovarian Cancer - Pain
1 Location available
- Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Na
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Head and Neck Cancer - Lymphoma - Nausea and Vomiting - Neuroblastoma - Ovarian Cancer - Sarcoma
1 Location available
- Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Pa
Conditions: Neuroblastoma - Pheochromocytoma
1 Location available
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Conditions: Kidney Cancer - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Pulmonary Complications - Sarcoma
38 Locations available
- Etoposide and Cisplatin in Treating Young Patients With Previously Untreated High-Risk Neuroblastoma Undergoing High-Dose Chemotherapy, Stem Cell Tran
Conditions: Neuroblastoma
2 Locations available
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
97 Locations available
- Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms - Thyroid Neoplasms - Parathyroid Neoplasms - Adrenal Neoplasm - Neuroblastoma
1 Location available
- To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Conditions: Sarcoma - Neuroblastoma - Wilms Tumor - Leukemia - Lymphoma - Brain Tumors
1 Location available
- Monitor Response to Treatment in Neuroblastoma Using 3'-Deoxy-3'-Fluorothymidine- Positron Emission Tomography (FLT-PET)
Conditions: Neuroblastoma
1 Location available
- Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo(Registered Trademark) (Vincristine Sulfate Liposomes Injection) in Chil
Conditions: Sarcoma - Neuroblastoma - Wilms Tumor - Leukemia - Lymphoma - Brain Tumors
1 Location available
- A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma
Conditions: Abdominal Neuroblastoma
1 Location available
- Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
Conditions: Neuroblastoma - Sarcoma
1 Location available
- Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Conditions: Rhabdomyosarcoma and Other Soft Tissue Sarcomas - Ewing's Sarcoma Family of Tumors - Osteosarcoma - Neuroblastoma - Brain Tumors
1 Location available
- Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Conditions: Neuroblastoma
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma Or Melanoma
Conditions: Neuroblastoma - Melanoma
1 Location available
- N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma
Conditions: Neuroblastoma
13 Locations available
- Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors Wi
Conditions: Adrenocortical Carcinoma - Gastrointestinal Carcinoid Tumor - Kidney Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
17 Locations available
- A Dose Finding and Safety Study of Oral LDE225 in Children
Conditions: Medulloblastoma, - Rhabdomyosarcoma, - Neuroblastoma, - Hepatoblastoma, - High Grade Glioma, - Astrocytoma
4 Locations available
- 131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Pheochromocytoma
Conditions: Neuroblastoma (Relapsed or Refractory) - Metastatic Pheochromocytoma
1 Location available
- Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
Conditions: Neuroblastoma
3 Locations available
- Neuroblastoma Biology Study
Conditions: Neuroblastoma
10 Locations available
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Neuroblastoma - Sarcoma
1 Location available
- Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Conditions: Neuroblastoma
1 Location available
- Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Conditions: Neuroblastoma
14 Locations available
- Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
Conditions: Severe Combined Immunodeficiency - Malignancy, Hematologic - Neuroblastoma - Neoplasm - Mucopolysaccharidosis I
1 Location available
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
86 Locations available
- High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow
Conditions: Neuroblastoma
1 Location available
- A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediat
Conditions: Leukemia - Lymphoma - Neuroblastoma - Sarcoma - Desmoplastic Small Round Cell Tumor
1 Location available
- Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors
Conditions: Neuroblastoma
1 Location available
|